Hours of grand jury proceedings were made public on Friday in the case of Breonna Taylor’s fatal shooting by police. The jury brought no criminal charges against the officers for her killing, angering many and setting off renewed protests.
Hours of grand jury proceedings were made public on Friday in the case of Breonna Taylor’s fatal shooting by police. The jury brought no criminal charges against the officers for her killing, angering many and setting off renewed protests.
Reistone Biopharma Co. Ltd. ("Reistone"), an innovative clinical stage biopharmaceutical company focused on developing novel medicines for immuno-inflammatory diseases with high unmet medical needs, today announced that SHR0302, a selective JAK1 inhibitor, met both the primary and secondary endpoints in its Phase 2 Study (QUARTZ2) for the treatment of moderate-to-severe atopic dermatitis (AD). All doses of SHR0302 demonstrated significantly superior response in its primary endpoint measured by the Investigator Global Assessment (IGA) Score and in the secondary endpoint of at least a 75% improvement in the Eczema Area Severity Index (EASI75) compared to placebo at week 12.
Liane Wells is sharing her tips to help other families save money.
Something changed in Yana Duke this year. The 49-year-old suburban Cincinnati woman is campaigning for President Donald Trump on social media, helping distribute yard signs and volunteering for such tasks as setting up for a recent visit to Cincinnati by his daughter Ivanka. With perennial swing-state Ohio appearing to be a toss-up in recent polling, the roles of campaign volunteers and grassroots groups in generating enthusiasm and turning out the vote will likely be crucial in the battle for the state’s 18 electoral votes.
Pakistan summoned the French ambassador in Islamabad on Monday in the latest expression of anger in the Muslim world over France displaying images of the Prophet Mohammad that Muslims consider blasphemous. In Bangladesh on Monday, protesters unfurled placards with a caricature of French President Emmanuel Macron and the words: "Macron is the enemy of peace", while over the weekend a group of Kuwaiti retailers removed French products from their shelves.
This article will reflect on the compensation paid to Jeff Sprecher who has served as CEO of Intercontinental...
The "Global Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The "Timber Frame Construction Market - Research & Analysis UK 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Engadget's daily tech news bulletin. Great USB-C chargers for your new iPhone, the end of an era at Samsung and more.
Tractor Supply Company (NASDAQ:TSCO) just released its third-quarter report and things are looking bullish. It was...
Microsoft Corp, which has largely evaded Washington's scrutiny of Big Tech companies and scored a lucrative $10 billion government contract under the Trump administration, has emerged as a significant backer of the Biden campaign. The Redmond, Washington-based software company is the fourth largest contributor to Democratic Presidential candidate Joe Biden's candidate campaign committee, according to data from OpenSecrets, a website which tracks money in politics and campaign finance records.
The Foxes secured a 1-0 victory at the Emirates Stadium as Jamie Vardy came off the bench to once again prove the scourge of Arsenal.
The increasing industrial expansion in the emerging regions along with demand for non-toxic and recyclable products is expected to provide opportunities for the expanded polypropylene foam market growthDallas, Texas, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The “Expanded Polypropylene (EPP) Foam Market by Type (Low Density, High Density & Porous PP), Application (Automotive, Packaging, Consumer Products), and by Region (North America, Europe, South America, Asia Pacific, MEA), and Global Forecast, 2018 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1569The worldwide increased value of expanded poly-propylene foam in 2019 was worth USD 1.22 billion. The rapid increase in automotive and consumer goods production ensures an increasing market for expanded polypropylene foam goods. The environmentally friendly and high-performance characteristics of expanded polypropylene (EPP) foam makes it a suitable substrate for a number of applications, such as seat components, bumpers, outdoor and indoor furnishings and FMCG products. The demand for EPP foam is expected to increase, as investment across major economies in manufacturing is rising.In many end-use industries, EPP foam is an additional consideration for the production processes. The growing demand for expanded polypropylene foam at global level would directly affect the production of these products. Based on use, EPP foams are available in varying densities called EPP grades of high density and EPP grades of low-density. High-density EPP foams have an outstanding strength and lower weight property and are used for energy storage applications which are important.Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/expanded-polypropylene-foam-marketThe report on the expanded demand for polypropylene foam explains the various characteristics of the global industry that are analyzed using a supply chain analysis approach. Furthermore, in terms of demand limitations, key industrial drivers and prospects, a range of performing components in the expanding polypropylene foam industry are included in the market report.The demand for expanded polypropylene foam demonstrates heavy competition between already well-known and emerging market participants. In addition, the enlarged polypropylene foam industry players are seeking prospective markets to gain strategic leadership from other industry players by joining mergers and acquisitions, alliances, purchasing other businesses and new start-ups, creating collaborations and partnerships, and extending their company presence.Place the direct purchase order at https://www.adroitmarketresearch.com/researchreport/purchase/1569Growing awareness of environmental issues and rising demand for fuel-efficient and lightweight cars are the main factors for the growth of the global EPP foam industry. Worldwide production and use of motor vehicles are growing, with global EPP foam industry expected to drive demand. In various industries including the packaging industry, aerospace, vehicle, etc. the recyclable and lightweight properties of EPP foam have allowed its use. The excellent strength and light weight along with enhanced absorption properties has facilitated its use in automotive crash prone parts. The use of high density EPP foam in heavy industrial packaging is expected to drive the growth of global EPP foam market.The rising construction activities in MEA region is attributed to the growth of expanded polypropylene foam market in the region. Due to the rising industrialization and construction activities in the region, Latin America is expected to develop rapidly over the projected period.Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1569Major Points from Table of Contents: Chapter 1 Introduction Chapter 2 Research Methodology Chapter 3 Executive Summary Chapter 4 Market Outlook Chapter 5 Expanded Polypropylene Foam Market by Type Chapter 6 Expanded Polypropylene Foam Market by Application Chapter 7 Expanded Polypropylene Foam Market by Region Chapter 8 Competitive Landscape Chapter 9 Company ProfilesAccess research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html About Us: Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.Contact Us: Ryan Johnson Account Manager - Global 3131 McKinney Ave Ste 600 Dallas, TX 75204 Email ID: firstname.lastname@example.org Phone No.: +1 972-362 -8199 Connect with us: Facebook | Twitter | LinkedIn
Investors still hope Tesla stock will join the S&P 500 index — for good reason. Getting added to the S&P 500 is like a golden ticket to gains this year.
Computer Services, Inc. (CSI) (OTCQX: CSVI), a provider of end-to-end fintech and regtech solutions, is joining the American Bankers Association (ABA) in supporting financial inclusion by enabling its bank customers to offer Bank On-certified accounts to consumers.
NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea, a leading medical grade skincare technology platform. Conversion Labs plans to use Restorsea’s intellectual property and proprietary formulations to create a best-in-class clinical-grade over-the-counter skincare line that will be marketed under the new Nava MD™ brand. The company plans to launch Nava MD in the first quarter of 2021.Restorsea’s clinically proven skincare technology platform was the result of more than $50 million invested in R&D and intellectual property development over the last several years, and has received 35 patents along with broad industry acclaim.Restorsea’s breakthrough clinical results have also been published in the peer-reviewed Journal of Drugs in Dermatology and Journal of Clinical and Aesthetic Dermatology. Nava MD will be the first and presently the only direct-to-consumer product line outside of Restorsea to offer this advanced skincare technology.Nava MD will be positioned as an online skincare and telehealth brand that will offer teledermatology services to patients in all 50 states. Teledermatology represents one of the fastest growing segments of the U.S. telehealth market. According to Fortune Business Insights, the teledermatology market is expected to grow at a 24.3% CAGR to $44.9 billion by 2027. “As with traditional brick and mortar dermatology, medical-grade over-the-counter products are an integral part of treating aging, dryness, acne, and other prevalent skin conditions,” stated Justin Schreiber, CEO of Conversion Labs. “Given the clinical results and industry acclaim, the Restorsea technology is in a league of its own. Incorporating it into our new direct-to-consumer teledermatology offering represents a major competitive advantage for Conversion Labs.”According to Restorsea founder and CEO, Patti Pao, who has launched more than 400 products for top brands like Avon, Elizabeth Arden, and Guerlain: “We are thrilled to partner with Conversion Labs for this historic launch of their Nava MD line featuring our advanced skincare technologies. We’re excited that it includes our natural proprietary biocatalyst exfoliator, Aquabeautine XL®.”Aquabeautine XL® is the only known natural substance that cleaves only dead skin cells, leaving living, healthy cells untouched. It makes skin look radiant, smooth, and even in tone and texture, and without the redness, irritation or thinning skin typically associated with the use of traditional exfoliators.“Our licensing of the Restorsea technology platform demonstrates our commitment to creating patented and proprietary telemedicine product lines that address large and underserved markets,” commented Conversion Labs CTO, Stefan Galluppi. “The more than $50 million invested in Restorsea’s intellectual property and product development came from a handful of the most sophisticated investors in the U.S. This level of investment is almost unprecedented in the skin care and dermatology world, and it is reflected in the quality and effectiveness of the Restorsea technology. We expect this to translate into great results for our patients and strong customer retention for Conversion Labs.”The company’s new cloud-based telemedicine platform, Veritas MD™, is expected to play a large role in the successful rollout of Nava MD, according to Galluppi: “Given the unique capabilities of Veritas MD, we are able to develop, introduce and deliver new products faster and more efficiently than ever before. Veritas MD not only provides incredible operational leverage by supporting greater scale at lower cost, but more importantly, its well-designed video-powered, mobile interface enhances the overall user experience for both patients and doctors.”According to Forrester Research, telehealth has “shifted into hyper-drive,” with virtual health care consultations on pace to top 1 billion by year end. The overall telemedicine market is expected to grow at 19.3% CAGR, reaching $175.5 billion by 2026.The teledermatology market has been seeing steady growth over the last few years; however, accelerated investments in healthcare technology and the recent pandemic have worked together to set the industry on a higher growth trajectory. Prior to the pandemic, teledermatology was viewed as generally suitable for most populations, but now it is considered an “absolute necessity” given the greater safety and cost-savings it provides.Nava MD is Conversion Labs’ fourth telemedicine brand. The success of these brands has been demonstrated by the company’s accelerating growth, with its annualized revenue run-rate currently triple over all of last year at more than $46.8 million.Conversion Labs’ annual recurring revenue (ARR) from subscriptions increased by $2.2 million or 13% to $19.3 million in September 2020 compared to August. ARR increased by $15.8 million or 458% versus September 2019.About Conversion Labs Conversion Labs, Inc. is a telemedicine company with a portfolio of online direct-to-consumer brands. The company’s brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit Conversionlabs.com.Important Cautions Regarding Forward-Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to Conversion Labs, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.Trademarks are the property of their respective owners.Company Contact Conversion Labs Juan Manuel Piñeiro Dagnery CFO Email ContactMedia and Investor Relations Contact Ron Both or Grant Stude CMA Investor Relations Tel (949) 432-7566 Email Contact
Matthew Loflin was coughing up blood, struggling to breathe and losing consciousness in his cell while awaiting trial on drug-possession charges in this historic Southern city. The jail’s senior medical staff – Dr. Charles Pugh and two well-credentialed nurses – agreed he needed hospitalization. When Loflin's X-ray showed a suspicious spot in his chest on April 7, Pugh tried another plan: He sent Loflin to a cardiologist, believing the specialist would want him hospitalized.
The uncaped Wasps duo are in the squad for the Six Nations finale against Italy and Autumn Nations Cup.
Futures fell sharply. The stock market could go either way, along with leaders such as Microsoft and Tesla. It's peak earnings week as elections loom and coronavirus cases surge.
Saaswedo, éditeur de solutions spécialiste du marché de la gouvernance des télécoms et du T.E.M, continue d’innover et lance une Appli End–User. Concrètement, la solution End–User permet d’informer les collaborateurs d’une entreprise et de les sensibiliser aux coûts et aux usages de téléphonie fixe et mobile et de services IT. Cette solution permet aux utilisateurs d’accéder aux principaux indicateurs de coûts répartis entre les abonnements et les consommations pour qu’ils puissent optimiser leur propre gestion télécom. Concrètement, l’application End–User intègre : -Une page d’accueil qui informe les utilisateurs du montant global des coûts et de son évolution par rapport au mois précédent. -D’un tableau de bord dynamique qui permet d’analyser les coûts selon les différents segments (téléphonie fixe, téléphonie mobile et services IT) et d’accéder aux détails des différents groupes de produits de facturation. -D’une fiche détaillée qui centralise l’ensemble des informations relatives au collaborateur : *L’organisation et le site auquel il est affecté, *Le détail des équipements qui lui sont alloués, *Les éléments de sa ligne mobile, son fournisseur, son compte et sous-compte de facturation, son numéro de SIM et son code PUK. Christophe Fornès de Saaswedo « Cette solution est dédiée aux entreprises qui souhaitent sensibiliser leurs collaborateurs aux coûts de la téléphonie. Impliquer et responsabiliser ses collaborateurs dans la gestion télécom permet une diminution significative du montant des factures. L’application End–User est interfacée avec la solution mytem360 de Saaswedo, qui optimise la gestion des parcs fixes, mobiles et services IT. Elle sera enrichie dans les prochains mois par des fonctions de gestion des demandes pour donner plus d’autonomie aux utilisateurs et alléger le travail des gestionnaires télécom»
Key Prominent Players Covered in the COVID-19 Diagnostics Market Research Report Are PerkinElmer Inc., Quest Diagnostics Incorporated, Quidel Corporation, Siemens Healthcare GmbH, Abbott, Thermo Fisher Scientific Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd, Danaher Corporation and other key market players.Pune, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, Research Institutes, and Others), and Regional Forecast, 2020-2027”. According to Johns Hopkins University, global COVID-19 infections reached 100,000 in just 60 days, growing to 200,000 in the next 12-14 days, and the recent addition of 100,000 cases has taken only 3 days. The calculation of the spread of this disease is based on the estimation of the “reproduction number” or R Naught (Ro). The UK Research and Innovation organization states that if the Ro goes above 1, exponential growth will be witnessed. As per a study published in the Journal of Clinical Medicine based on the virus transmission rate in Wuhan, the Ro was computed to be between 2.49 and 2.63. Such rapid transmission of the virus has surged the demand for coronavirus diagnostics tools and kits, which is boosting the growth of this market. Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/covid-19-diagnostics-market-103291 The report states that the value of the global market stood at USD 6.22 billion in 2020 and also provides the following: * Detailed analysis of the short-term and long-term impact of the COVID-19 pandemic on the market; * Comprehensive insights into the upcoming opportunities in the market; * In-depth of the market, drivers, restraints, and segments; and * Careful examination of the regional developments, competitive landscape, and rising investment pockets for the market. Concerted Efforts towards Developing COVID Detection Tests to Accelerate GrowthWith the COVID-19 pandemic showing no signs of abatement, medical and regulatory bodies are collaborating to encourage innovation and speed up research in developing coronavirus detection tools. For instance, in April 2020, the National Institutes of Health in the US announced the launch of Rapid Acceleration of Diagnostics (RADx) initiative with a funding of USD 1.5 billion to commercialize and widen the accessibility of COVID-19 testing. Similarly, in June 2020, the US Food and Drug Administration (FDA) joined the COVID-19 Diagnostics Evidence Accelerator created by the Friends of Cancer Research and Reagan-Udall Foundation with the aim to evaluate the performance of PCR and antibody tests for COVID. Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/covid-19-diagnostics-market-103291 High Number of COVID-19 Cases to Give North America Leading Market PositionThe United States is one of the worst-hit countries in the world by the coronavirus pandemic, with the number of cases as of June 2020 standing at 2.68 million and 129,000 deaths. In response, the US government is injecting more funds into medical research facilities to accelerate development of COVID-19 diagnostics and widen the testing net in the country. The region’s market size in 2020 stood at USD 2.20 billion. In Europe, the virus is spreading at a furious pace, with the UK, Italy, Spain, France, and Germany having the highest number of cases. Quick adoption of advanced detection tools in the region will enable it to expand its footprint in the COVID-19 diagnostics market share in the immediate future. Heavy investments by governments in Asia Pacific in the healthcare sector are expected to favor market growth in the region. Quick Buy - COVID-19 Diagnostics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103291 Regulatory Support to Novel Diagnostic Solutions to Encourage InnovationThe coronavirus is tightening its hold on the world and pharmaceuticals and governments are in a race against time to develop and launch quick and accurate diagnostic tests for this deadly virus. As a result, bodies such as the FDA are providing the necessary support to companies by removing unnecessary regulatory barriers, which is encouraging other players to innovate. Industry Developments: * May 2020: Sofia 2 SARS Antigen FIA test developed by Quidel was green lit by the FDA, making it the first antigen test approved in the US for the detection of COVID-19. These tests identify unique protein fragments found on the outer walls of the coronavirus and deliver quick results. * March 2020: The US FDA cleared Abbott’s molecular point-of-care test for detection of COVID in patients through its Emergency Use Authorization (EUA). The test promises to deliver positive results in 5 minutes and negative results in 13 minutes. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/covid-19-diagnostics-market-103291 List of Key Players Covered in this COVID-19 Diagnostics Market Report: * PerkinElmer Inc. (Massachusetts, U.S) * Quest Diagnostics Incorporated (New Jersey, U.S) * Quidel Corporation (California, U.S) * Siemens Healthcare GmbH (Germany) * Abbott (Illinois, U.S) * Thermo Fisher Scientific Inc. (Massachusetts, U.S) * bioMérieux SA (France) * F. Hoffmann-La Roche Ltd (Switzerland) * Danaher Corporation (Washington D.C, U.S) Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/covid-19-diagnostics-market-103291 COVID-19 Diagnostics Market Segmentations:By Product• Instruments • Reagents & KitsBy Technology• Polymerase Chain Reaction (PCR)• Enzyme-linked Immunosorbent Assay (ELISA)• Point-of-care (POC)• OthersBy Sample Type• Oropharyngeal & Nasopharyngeal Swabs• Blood• Urine• OthersBy End User• Hospital & Clinics• Laboratories & Diagnostics Centers• Research Institutes• OthersBy Geography• North America (U.S. and Canada)• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)• Latin America (Brazil, Mexico, and Rest of Latin America)• The Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa) SECONDARY DATA SOURCES THAT WE REFER TO: * Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market * Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc. * Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics * Industry journals and paid databasesSECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION: * Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies * Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc. * Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility * Number of procedures and average price of procedures * Replacement rate and pricing of capital equipment * Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities * Market & technological trends, new product developments, product pipeline. Have a Look at Related Reports:In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026Hepatitis C Drug Market Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025Digital Radiography Market Share and Global Trend By Product Type (Computed Radiography, Direct Digital Radiography), Application (General, Radiography Dentistry, Oncology, Orthopedic) End User (Hospital, Clinics, Diagnostic Centers) and Geography Forecast till 2026 About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us:Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: email@example.com Fortune Business Insights™ LinkedIn | Twitter | Blogs Press Release: https://www.fortunebusinessinsights.com/press-release/global-covid-19-diagnostics-market-10100